Synovial Fibroblasts Selectively Suppress Th1 Cell Responses through IDO1-Mediated Tryptophan Catabolism
暂无分享,去创建一个
S. Mohapatra | S. Gay | M. Löhning | H. Lorenz | C. Opitz | M. Plattén | I. Oezen | T. Tretter | M. Neidhart | L. Tykocinski | S. Krienke | P. Saikali | Anna-Marie Lauffer | A. Bohnen | Nathalie-Christin Kaul | I. Adam | A. Lauffer
[1] C. Plass,et al. Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer , 2017, Oncoimmunology.
[2] S. Jung,et al. Downregulation of Tryptophan-related Metabolomic Profile in Rheumatoid Arthritis Synovial Fluid , 2015, The Journal of Rheumatology.
[3] H. Lorenz,et al. Activated human B cells induce inflammatory fibroblasts with cartilage-destructive properties and become functionally suppressed in return , 2015, Annals of the rheumatic diseases.
[4] D. Furst,et al. Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. , 2014, Rheumatology.
[5] Eugenia G. Giannopoulou,et al. Modulation of TNF-Induced Macrophage Polarization by Synovial Fibroblasts , 2014, The Journal of Immunology.
[6] R. Gay,et al. Inhibition of Spermidine/Spermine N1‐Acetyltransferase Activity: A New Therapeutic Concept in Rheumatoid Arthritis , 2014, Arthritis & rheumatology.
[7] S. Akira,et al. The enzyme Cyp26b1 mediates inhibition of mast cell activation by fibroblasts to maintain skin-barrier homeostasis. , 2014, Immunity.
[8] D. Fox,et al. T cell subsets and their role in the pathogenesis of rheumatic disease , 2014, Current opinion in rheumatology.
[9] P. Miossec,et al. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis , 2014, European journal of immunology.
[10] E. Lubberts,et al. Synovial Fibroblasts Directly Induce Th17 Pathogenicity via the Cyclooxygenase/Prostaglandin E2 Pathway, Independent of IL-23 , 2013, The Journal of Immunology.
[11] D. Munn,et al. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. , 2013, Trends in immunology.
[12] P. Zhu,et al. Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: implication to clinical therapeutics. , 2012, Autoimmunity reviews.
[13] Yufang Shi,et al. How mesenchymal stem cells interact with tissue immune responses. , 2012, Trends in immunology.
[14] M. Weller,et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor , 2011, Nature.
[15] V. Kindler,et al. Human Bone Marrow Stromal Cells and Skin Fibroblasts Inhibit Natural Killer Cell Proliferation and Cytotoxic Activity , 2011, Cell transplantation.
[16] M. Kamal,et al. Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA , 2011, Clinical Rheumatology.
[17] M. Lai,et al. Amelioration of rat collagen-induced arthritis through CD4+ T cells apoptosis and synovial interleukin-17 reduction by indoleamine 2,3-dioxygenase gene therapy. , 2011, Human gene therapy.
[18] A. Skapenko,et al. Role of Th17 cells in human autoimmune arthritis. , 2010, Arthritis and rheumatism.
[19] A. Silman,et al. UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .
[20] A. Silman,et al. Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .
[21] B. Larijani,et al. Local Expression of Indoleamine 2,3 Dioxygenase in Syngeneic Fibroblasts Significantly Prolongs Survival of an Engineered Three-Dimensional Islet Allograft , 2010, Diabetes.
[22] L. Casteilla,et al. Human Fibroblasts Share Immunosuppressive Properties with Bone Marrow Mesenchymal Stem Cells , 2010, Journal of Clinical Immunology.
[23] G. Firestein,et al. Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis , 2010, Immunological reviews.
[24] R. Gay,et al. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. , 2009, Arthritis and rheumatism.
[25] B. Baban,et al. IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells1 , 2009, The Journal of Immunology.
[26] D. Essex,et al. Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis. , 2009, Arthritis and rheumatism.
[27] M. Weller,et al. Toll‐Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow‐Derived Mesenchymal Stem Cells by Inducing Indoleamine‐2,3‐dioxygenase‐1 via Interferon‐β and Protein Kinase R , 2009, Stem cells.
[28] I. Pinchuk,et al. PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity. , 2008, Gastroenterology.
[29] A. Mandelin,et al. TH-17 cells in rheumatoid arthritis , 2008, Arthritis research & therapy.
[30] S. Chevalier,et al. Chronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes , 2008, The Journal of Immunology.
[31] V. Duronio,et al. Differential immunosuppressive effect of indoleamine 2,3-dioxygenase (IDO) on primary human CD4+ and CD8+ T cells , 2008, Molecular and Cellular Biochemistry.
[32] A. Cope,et al. The Antiproliferative Effect of Mesenchymal Stem Cells Is a Fundamental Property Shared by All Stromal Cells1 , 2007, The Journal of Immunology.
[33] A. Cope,et al. The central role of T cells in rheumatoid arthritis. , 2007, Clinical and experimental rheumatology.
[34] M. Haniffa,et al. Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells1 , 2007, The Journal of Immunology.
[35] W. Wick,et al. Tryptophan degradation in autoimmune diseases , 2007, Cellular and Molecular Life Sciences.
[36] T. Glant,et al. Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice , 2007, Arthritis research & therapy.
[37] D. Fox,et al. Cells of the synovium in rheumatoid arthritis. T lymphocytes , 2007, Arthritis research & therapy.
[38] Yuan Wang,et al. Synovial Autoreactive T Cells in Rheumatoid Arthritis Resist IDO-Mediated Inhibition1 , 2006, The Journal of Immunology.
[39] T. Šarić,et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. , 2006, Blood.
[40] J. Lord,et al. Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. , 2006, Arthritis and rheumatism.
[41] U. Grohmann,et al. The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor ζ-Chain and Induce a Regulatory Phenotype in Naive T Cells1 , 2006, The Journal of Immunology.
[42] P. Lipsky,et al. Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[43] M. Albert,et al. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. , 2005, Blood.
[44] B. Baban,et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. , 2005, Immunity.
[45] W. B. van den Berg,et al. The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models , 2004, Arthritis research & therapy.
[46] S. Nakae,et al. Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice 1 , 2003, The Journal of Immunology.
[47] R. Paules,et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. , 2003, Molecular cell.
[48] J. Lord,et al. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. , 2001, Trends in immunology.
[49] J. Banchereau,et al. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages , 2000, Nature Immunology.
[50] P. Lipsky,et al. Altered memory T cell differentiation in patients with early rheumatoid arthritis. , 1999, Journal of immunology.
[51] Y. Shimabukuro,et al. Interferon-gamma-dependent immunosuppressive effects of human gingival fibroblasts. , 1992, Immunology.
[52] N. Bottini,et al. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors , 2013, Nature Reviews Rheumatology.
[53] Xiaoyue Lin,et al. Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute. , 2006, The Journal of investigative dermatology.